The Cutaneous Silent Period in Motor Neuron Disease

• Autor(a) principal: Castro, J
• Data de Publicação: 2021
• Outros Autores: Swash, M, Carvalho, M
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.17/4313
• topic: HSJ NEU; Adult; Female; Male; Humans; Amyotrophic Lateral Sclerosis / physiopathology*; Middle Aged; Electromyography / methods; Fingers / innervation; Fingers / physiology; Motor Neurons / physiology; Muscle Contraction*; Muscle, Skeletal / innervation; Muscle, Skeletal / physiology; Muscular Atrophy, Spinal / physiopathology*; Pyramidal Tracts / physiopathology; Reaction Time; Skin / innervation

Objective: To investigate the cutaneous silent period (CSP) by measuring its onset latency, duration and amount signal suppression in patients with motor neuron disease (MND) grouped according to the intensity of upper motor neuron involvement (UMN), and to test the effect of contralateral hand contraction. Methods: Painful stimulation was applied at the V finger, and contraction recorded from the abductor digiti minimi (ADM) muscle (baseline condition). Afterwards, CSP was studied during strong contralateral ADM contraction (test condition). 10-15 consecutive traces were recorded for each condition, signals were rectified, averaged, and analyzed offline. Results: 46 patients were investigated, 15 with progressive muscular atrophy (PMA), 16 with typical amyotrophic lateral sclerosis (ALS), 15 with primary lateral sclerosis/predominant UMN-ALS (PLS+UMN-ALS), and 28 controls. In the baseline condition, all MND groups showed delayed onset latencies (p = 0.001). There was no significant difference in the CSP duration. Suppression was lower in the PLS + UMN-ALS group (p = 0.004). In the control group, contralateral contraction did not change CSP, but onset latency shortened significantly in the PMA group. Conclusions: CSP onset latency is delayed in all investigated groups of MND, including in PMA, indicating subclinical UMN involvement. Changes in CSP can indicate UMN lesion in MND. Significance: CSP should be explored to identify UMN involvement in MND.